According to a new report, published by KBV research, The Global Telecare Market size is expected to reach $5.5 billion by 2027, rising at a market growth of 5.7% CAGR during the forecast period.
The Remote Medication Management segment is showcasing a CAGR of 6.1% during (2021 - 2027). Demand for virtual face-to-face interactions to address chronic illness problems is increasing and hence, this factor is increasing the implementation of remote medication management. In addition, an increase in the usage of telecare platforms such as pill reminders by individuals to ensure that they take their medications on time, with the correct dosage, and to avoid any adverse drug events is also flourishing the growth of the remote medication management segment.
The North America market dominated the Global Telecare Market by Region 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1.9 billion by 2027. The Europe market is experiencing a CAGR of 4.9% during (2021 - 2027). Additionally, The Asia Pacific market would witness a CAGR of 7.4% during (2021 - 2027).
Full Report: https://www.kbvresearch.com/telecare-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, AllScripts Healthcare Solutions, Inc., AT&T, Inc., Samsung Electronics Co., Ltd., Apple, Inc., Qualcomm, Inc., and Google LLC.
By Product Type
By Geography
Companies Profiled
Unique Offerings 
